We herein showed that the CaMKII inhibitors, KN-93 and acremomannolipin A, ameliorated the development of diet-induced obesity without any significant health issues examined in mice. The gene discussed is CAMK2G; the disease is obesity due to melanocortin 4 receptor deficiency.